Claudio Mosse

Chief

VA Tennessee Valley Healthcare System

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Claudio Mosse is a Chief at the VA Tennessee Valley Healthcare System in the United States. His research primarily focuses on hematologic malignancies, including chronic lymphocytic leukemia and acute leukemia treatments. He has contributed to significant publications involving innovative therapeutic strategies and clinical guidelines in oncology. His work emphasizes the impact of novel combination therapies and disease management in complex hematological conditions.

Articles (9)

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Somedeb Ball

Vanderbilt University Medical Center

UNITED STATES

View details

nadia khan

Assistant Professor

Fox Chase Cancer Center

UNITED STATES

View details

Riccardo Valdez

University of Michigan

UNITED STATES

View details

Anthony Olszanski

Vice Chair Research; Associate Professor

UNITED STATES

View details

April K.S. Salama

Duke University Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Claudio Mosse

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma, Version 2.2024

Complete remission in a case of acute undifferentiated leukemia with novel combination therapy of FLAG-IDA and venetoclax

Idiopathic Multicentric Castleman Disease With Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Insufficiency, and Organomegaly (TAFRO) Syndrome in a Liver Transplant Recipient.

NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022

miR-378-3p Knockdown Recapitulates Many of the Features of Myelodysplastic Syndromes

Uveal melanoma, version 1.2019 featured updates to the NCCN guidelines

Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myeloma

Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML0431

Sustained remission in a patient with PDGFR-beta-rearranged T-lymphoblastic lymphoma and complete remission with dasatinib

Collaborators (5)

Somedeb Ball

nadia khan

Riccardo Valdez

Anthony Olszanski

April K.S. Salama

Make your next move.